An antiapoptotic role for the receptor tyrosine kinase Axl in cutaneous squamous cell carcinoma

An antiapoptotic role for the receptor tyrosine kinase Axl in cutaneous squamous cell carcinoma

Bibliographic Details
Main Authors:	Papadakis, E, Vyas, J, Patel, N, Ghali, L, Storey, A, O'Toole, E
Format:	Conference item
Published:	2009

Similar Items

A role for the receptor tyrosine kinase, Axl, in cutaneous squamous cell carcinoma survival
by: Papadakis, E, et al.
Published: (2008)

A role for the receptor tyrosine kinase, Axl, in squamous cell carcinoma invasion and survival
by: Papadakis, E, et al.
Published: (2008)

A role for the receptor tyrosine kinase Axl in regulating NF-kappa B activity in cutaneous squamous cell carcinomas
by: Papadakis, E, et al.
Published: (2009)

Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.
by: Papadakis, E, et al.
Published: (2011)

The Receptor Tyrosine Kinase AXL in Cancer Progression
by: Erinn B. Rankin, et al.
Published: (2016-11-01)

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
by: Mohan Shankar Gopinatha Pillai, et al.
Published: (2023-06-01)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
by: Xinyan Wu, et al.
Published: (2021-08-01)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma with loss of type VII collagen
by: Martin, V, et al.
Published: (2008)

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
by: Kristina Breitenecker, et al.
Published: (2023-09-01)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma cells with loss of type VII collagen
by: Martins, V, et al.
Published: (2009)

AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
by: Pardis Mohammadzadeh, et al.
Published: (2023-10-01)

AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
by: Edward T Schmid, et al.
Published: (2016-06-01)

Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.
by: Martins, V, et al.
Published: (2009)

Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
by: Alberto Repici, et al.
Published: (2024-02-01)

Inhibition of AXL receptor tyrosine kinase enhances brown adipose tissue functionality in mice
by: Vissarion Efthymiou, et al.
Published: (2023-07-01)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Xun Hui Yeo, et al.
Published: (2023-06-01)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Yeo, Xun Hui, et al.
Published: (2023)

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
by: Pinato, D, et al.
Published: (2019)

Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
by: Liang Gao, et al.
Published: (2023-08-01)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
by: Lea Scherschinski, et al.
Published: (2022-01-01)

A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
by: Ahmad Nasimian, et al.
Published: (2023-02-01)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
by: Nataliya Pidkovka, et al.
Published: (2023-07-01)

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
by: Siyang Yan, et al.
Published: (2019-11-01)

Correction: Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
by: Liang Gao, et al.
Published: (2023-08-01)

Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Xun Hui Yeo, et al.
Published: (2023-07-01)

AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma
by: Federica Zito Marino, et al.
Published: (2022-12-01)

The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications
by: Martha Wium, et al.
Published: (2021-03-01)

AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis
by: Marie-Anne Goyette, et al.
Published: (2022-01-01)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
by: Xiaojie Chen, et al.
Published: (2022-11-01)

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
by: Marie-Anne Goyette, et al.
Published: (2023-12-01)

Loss of type VII collagen in squamous cell carcinoma results in increased invasion with disorganized epithelial differentiation and epithelial-mesenchymal transition
by: Martins, V, et al.
Published: (2008)

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
by: Diogo Alpuim Costa, et al.
Published: (2018-05-01)

Tyrosine Kinase Receptors in Oncology
by: Jorge Esteban-Villarrubia, et al.
Published: (2020-11-01)

Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors
by: Ryota Nakamura, MD, et al.
Published: (2023-06-01)

Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas
by: Joanna M. Janus, et al.
Published: (2017-07-01)

Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer
by: Yunong Xie, et al.
Published: (2024-02-01)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
by: Sosuke Matsumura, et al.
Published: (2023-02-01)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
by: Lina Lüttich, et al.
Published: (2021-04-01)

Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma
by: Yi-Ping Hsieh, et al.
Published: (2022-04-01)

Proteolytic Cleavage of Receptor Tyrosine Kinases
by: Hao Huang
Published: (2021-04-01)